Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCHW) Common Equity (2022 - 2025)

Historic Common Equity for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to -$7.7 million.

  • Envoy Medical's Common Equity rose 5868.52% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.7 million, marking a year-over-year increase of 5868.52%. This contributed to the annual value of -$18.8 million for FY2024, which is 96092.34% down from last year.
  • Per Envoy Medical's latest filing, its Common Equity stood at -$7.7 million for Q3 2025, which was up 5868.52% from -$29.9 million recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Common Equity registered a high of $4.8 million during Q3 2023, and its lowest value of -$47.5 million during Q1 2023.
  • For the 4-year period, Envoy Medical's Common Equity averaged around -$20.5 million, with its median value being -$18.8 million (2024).
  • As far as peak fluctuations go, Envoy Medical's Common Equity soared by 12758.31% in 2023, and later tumbled by 96092.34% in 2024.
  • Envoy Medical's Common Equity (Quarter) stood at -$36.2 million in 2022, then soared by 95.09% to -$1.8 million in 2023, then plummeted by 960.92% to -$18.8 million in 2024, then surged by 59.34% to -$7.7 million in 2025.
  • Its last three reported values are -$7.7 million in Q3 2025, -$29.9 million for Q2 2025, and -$24.2 million during Q1 2025.